Literature DB >> 25262266

Differences in sex-related bleeding and outcomes after percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry.

Hussein Othman1, Sherezade Khambatta1, Milan Seth2, Thomas A Lalonde1, Howard S Rosman1, Hitinder S Gurm2, Rajendra H Mehta3.   

Abstract

BACKGROUND: Bleeding after percutaneous coronary intervention (PCI) is more common in women than in men. However, the relationship of sex and bleeding with outcomes is less well studied.
METHODS: We examined the sex-related differences in the incidence of bleeding and its association with in-hospital outcomes among 96,637 patients undergoing PCI enrolled in the BMC2 registry (2010-2012).
RESULTS: Women had higher bleeding rate than did men (3.9% vs 1.8%) and thus received more blood transfusions (59% vs 41%). Both men (odds ratio [OR] 2.25, 95% CI 1.70-2.97) and women (OR 3.13, 95% CI 2.42-4.07) who bled had higher risk-adjusted death compared with their counterparts without bleeding. Although there was no difference in adjusted mortality between women and men without bleeding (OR 1.14, 95% CI 0.99-1.32), among patients who bled, adjusted death was higher in women (OR 1.28, 95% CI 1.11-1.47). Among patients with bleeding, transfusion was associated with similar increased risk of death in both men (OR 2.00, 95% CI 1.23-3.25) and women (OR 2.18, 95% CI 1.31-3.63) compared with their counterparts without transfusion(s).
CONCLUSIONS: Post-PCI bleeding was more common and associated with higher-than-expected in-hospital death in women compared with men with bleeding. This trend for higher death in women with bleeding was independent of transfusion. Quality efforts geared toward reducing bleeding in general, with a special focus on women, need to be explored to help reduce post PCI-bleeding and mortality and decrease sex-related disparity in adverse events.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25262266     DOI: 10.1016/j.ahj.2014.07.012

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

Review 1.  Vascular Access-Related Complications in Women: Temporal Trends, Emerging Data, and the Current State of Interventional Cardiology Practice.

Authors:  Yohan Chacko; Rushi V Parikh; Jennifer A Tremmel
Journal:  Curr Atheroscler Rep       Date:  2018-06-08       Impact factor: 5.113

Review 2.  Sex differences in inflammation during atherosclerosis.

Authors:  DeLisa Fairweather
Journal:  Clin Med Insights Cardiol       Date:  2015-04-19

3.  The impact of optimal medical therapy at discharge on mortality in patients with coronary artery disease.

Authors:  Shi-Jian Chen; Wei Liu; Bao-Tao Huang; Jia-Yu Tsauo; Xiao-Bo Pu; Yong Peng; Mao Chen; De-Jia Huang
Journal:  J Geriatr Cardiol       Date:  2017-02       Impact factor: 3.327

4.  Gender differences of in-hospital outcomes in patients undergoing percutaneous coronary intervention in the drug-eluting stent era.

Authors:  Hack-Lyoung Kim; Jae-Sik Jang; Myung-A Kim; Jae-Bin Seo; Woo-Young Chung; Sang-Hyun Kim; Seung-Jung Park; Tae-Jin Youn; Myeong-Ho Yoon; Jae-Hwan Lee; Kiyuk Chang; Myung Ho Jeong; Rak Kyeong Choi; Myeong-Ki Hong; Hyo-Soo Kim
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 5.  Gender Influences on Shoulder Arthroplasty.

Authors:  Nicole J Hung; Stephanie E Wong
Journal:  Curr Rev Musculoskelet Med       Date:  2022-01-04

6.  Gender disparities in red blood cell transfusion in elective surgery: a post hoc multicentre cohort study.

Authors:  Hans Gombotz; Günter Schreier; Sandra Neubauer; Peter Kastner; Axel Hofmann
Journal:  BMJ Open       Date:  2016-12-13       Impact factor: 2.692

7.  Influence of factor XIII activity on post-operative transfusion in congenital cardiac surgery-A retrospective analysis.

Authors:  Fabian B Fahlbusch; Thomas Heinlein; Manfred Rauh; Sven Dittrich; Robert Cesnjevar; Julia Moosmann; Jennifer Nadal; Matthias Schmid; Frank Muench; Michael Schroth; Wolfgang Rascher; Hans-Georg Topf
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.